PNC Financial Services Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-80	Closed	-$71	–	4892
2022 Q4	$71	Sell	80 -1,980	-96%	-$2.63K	﹤0.01%	4713
2022 Q3	$3K	Sell	2,060 -16,000	-89%	-$36.3K	﹤0.01%	4133
2022 Q2	$36K	Buy	18,060 +15,000	+490%	+$25.9K	﹤0.01%	3194
2022 Q1	$7K	Hold	3,060	–	–	﹤0.01%	3929
2021 Q4	$14K	Sell	3,060 -2,282	-43%	-$14.2K	﹤0.01%	3693
2021 Q3	$41K	Hold	5,342	–	–	﹤0.01%	3189
2021 Q2	$51K	Buy	5,342 +1,982	+59%	+$15.8K	﹤0.01%	3063
2021 Q1	$28K	Sell	3,360 -1,564	-32%	-$16.5K	﹤0.01%	3278
2020 Q4	$34K	Sell	4,924 -1,776	-27%	-$14.3K	﹤0.01%	3129
2020 Q3	$75K	Sell	6,700 -24,201	-78%	-$221K	﹤0.01%	2488
2020 Q2	$194K	Buy	+30,901	New	+$118K	﹤0.01%	1951
2018 Q4	–	Sell	-4,500	Closed	-$20K	–	4231
2018 Q3	$20K	Hold	4,500	–	–	﹤0.01%	3456
2018 Q2	$32K	Hold	4,500	–	–	﹤0.01%	3266
2018 Q1	$23K	Buy	+4,500	New	+$32K	﹤0.01%	3378
2017 Q2	–	Sell	-2,400	Closed	-$9K	–	4251
2017 Q1	$9K	Hold	2,400	–	–	﹤0.01%	3585
2016 Q4	$12K	Hold	2,400	–	–	﹤0.01%	3431
2016 Q3	$19K	Hold	2,400	–	–	﹤0.01%	3256
2016 Q2	$13K	Hold	2,400	–	–	﹤0.01%	3440
2016 Q1	$13K	Hold	2,400	–	–	﹤0.01%	3467
2015 Q4	$21K	Sell	2,400 -74,261	-97%	-$626K	﹤0.01%	3282
2015 Q3	$643K	Buy	+76,661	New	+$1.22M	﹤0.01%	1422